Insulin glargine and lixisenatide and Pan C 500
Determining the interaction of Insulin glargine and lixisenatide and Pan C 500 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: bioflavonoids
Brand name: Amino-Opti-C, Limbrel, P-1000, Pan C 500, Peridin-C, Rutin, Span C, Vasoflex D1
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Pan-2400
- Insulin glargine and lixisenatide-Panatuss DXP
- Insulin glargine and lixisenatide-Panatuss PED
- Insulin glargine and lixisenatide-Panatuss PED Drops
- Insulin glargine and lixisenatide-Pancof HC
- Insulin glargine and lixisenatide-Pancof XP
- Pan C 500-Insulin glargine and lixisenatide Subcutaneous
- Pan C 500-Insulin glargine, recombinant Subcutaneous
- Pan C 500-Insulin glulisine
- Pan C 500-Insulin Glulisine (Cartridges and Pens)
- Pan C 500-Insulin Glulisine (Vials)
- Pan C 500-Insulin glulisine Subcutaneous